Cognex (CGNX) NASDAQ pre-market $56.72 19 Feb 2026: AI demand guides outlook

Cognex Corporation (CGNX) trades $56.72 pre-market on NASDAQ in the United States on 19 Feb 2026. CGNX stock has climbed year-to-date 53.59% as machine vision demand from AI and automation sectors lifts revenue visibility. Today’s pre-market price sits near the 52-week high of $59.88 and above the 50-day average $39.47. Investors will watch upcoming catalysts including analyst commentary and the next earnings date of 2026-04-29 as they weigh valuation against growth in AI-related end markets.

Quick snapshot of CGNX stock performance

CGNX stock trades on NASDAQ in USD with a market cap of $9.40B. Today’s pre-market price is $56.72, previous close $57.09, day range $56.27–$57.86, and average volume 1,994,723 shares. The company reports EPS $0.68 and a trailing P/E of 83.41. Recent momentum shows 1-month change +38.61% and year-to-date +53.59%. This section gives a concise reference to liquidity, valuation, and intraday context for traders and long term holders.

Why AI demand matters for CGNX stock

Cognex sells machine vision systems used in automated inspection and robotic guidance. Growth in AI-driven factory automation has lifted order volumes across automotive and electronics. Management highlighted those markets at a recent Barclays presentation source. Strong demand supports revenue per share $5.95 and R&D intensity at 13.98% of revenue, which drives product differentiation in deep learning vision software.

CGNX stock financials and valuation snapshot

Cognex shows solid cash metrics with free cash flow per share $1.42 and cash per share $2.01. The balance sheet is conservative with debt to equity 0.05 and current ratio 3.80. Valuation multiples remain rich: price to sales 9.49 and price to book 6.32. Analysts rate the stock mostly as buy with 12 buys and 2 holds, per consensus data, which supports the premium multiple despite a high P/E.

CGNX stock technicals and trading signals

Technical indicators show strong short-term momentum. RSI is 78.14 indicating overbought conditions. MACD histogram is positive with MACD 4.46 and signal 2.59. Bollinger upper band is 58.15 and middle 44.12, signaling recent volatility expansion. Traders should note average volume 2,271,843 today versus 50-day average volume 1,994,723. These signals suit momentum strategies but increase pullback risk for swing trades.

Meyka AI rates CGNX with a score out of 100 and forecast

Meyka AI rates CGNX with a score out of 100: 72.52 (B+), Suggestion: BUY. This grade factors in S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a monthly price of $55.55 and a 1-year level of $31.78. Versus the current $56.72, the monthly projection implies -2.06%, and the 1-year projection implies -43.97%. Forecasts are model-based projections and not guarantees. For the full company context see MarketBeat news coverage source and our Meyka CGNX page for real-time updates.

Risks and catalysts shaping CGNX stock outlook

Key catalysts include stronger AI-driven order flow, margin expansion from software sales, and new product ramps. Risks include valuation compression if growth slows, cyclicality in industrial end markets, and a high trailing P/E of 83.41 that raises expectations. Monitor short interest reports and quarterly results. A clearer demand picture at the next earnings release on 2026-04-29 will likely drive a material price move.

Final Thoughts

Key takeaways for CGNX stock: the pre-market price $56.72 on NASDAQ reflects strong AI-related demand and a concentrated momentum trade. Valuation is stretched with trailing P/E 83.41, price to sales 9.49, and price to book 6.32, which increases sensitivity to execution. Meyka AI’s model projects a near-term monthly level of $55.55 (-2.06% vs current) and a 1-year projection of $31.78 (-43.97% vs current). Realistic price targets we use for scenario planning are conservative $45.00 (down -20.67%), base $60.00 (up +5.79%), and bull $75.00 (up +32.24%). Investors who focus on AI exposure should weigh growth potential against premium multiples and use position sizing to manage downside. This analysis uses company financials, technical signals, sector context, and Meyka AI-powered market analysis to frame risk and opportunity, not as investment advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.